The latest closing stock price for Avalo Therapeutics as of September 18, 2024 is 9.18.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-999 today, roughly -1 times their original investment - a -54.74% compound annual growth rate over 9 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 52.33, which is 470% above the current share price.
The Avalo Therapeutics 52-week low stock price is 3.95, which is 57% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 13.43.
An investor who bought $1,000 worth of Avalo Therapeutics stock at the IPO in 2015 would have $-999 today, roughly -1 times their original investment - a -54.74% compound annual growth rate over 9 years.
The all-time high Avalo Therapeutics stock closing price was 20793.60 on February 27, 2019.
The Avalo Therapeutics 52-week high stock price is 52.33, which is 470% above the current share price.
The Avalo Therapeutics 52-week low stock price is 3.95, which is 57% below the current share price.
The average Avalo Therapeutics stock price for the last 52 weeks is 13.43.